NO995800L - Anvendelse av oligosakkarid for forhindring av blodkoagulering i ekstrakorporeale blodkretser - Google Patents

Anvendelse av oligosakkarid for forhindring av blodkoagulering i ekstrakorporeale blodkretser

Info

Publication number
NO995800L
NO995800L NO995800A NO995800A NO995800L NO 995800 L NO995800 L NO 995800L NO 995800 A NO995800 A NO 995800A NO 995800 A NO995800 A NO 995800A NO 995800 L NO995800 L NO 995800L
Authority
NO
Norway
Prior art keywords
oligosaccharide
circuits
prevent
extracorporeal
extracorporeal blood
Prior art date
Application number
NO995800A
Other languages
English (en)
Other versions
NO325142B1 (no
NO995800D0 (no
Inventor
Jean-Marc Herbert
Jacobus Christianus J Stiekema
Original Assignee
Akzo Nobel Nv
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Synthelabo filed Critical Akzo Nobel Nv
Publication of NO995800D0 publication Critical patent/NO995800D0/no
Publication of NO995800L publication Critical patent/NO995800L/no
Publication of NO325142B1 publication Critical patent/NO325142B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
NO19995800A 1997-05-27 1999-11-26 Anvendelse av oligosakkarid for fremstilling av et medikament for forhindring av blodkoagulering i ekstra korporlige blodkretser NO325142B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201586 1997-05-27
PCT/EP1998/003174 WO1998053829A1 (en) 1997-05-27 1998-05-22 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits

Publications (3)

Publication Number Publication Date
NO995800D0 NO995800D0 (no) 1999-11-26
NO995800L true NO995800L (no) 1999-11-26
NO325142B1 NO325142B1 (no) 2008-02-11

Family

ID=8228366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995800A NO325142B1 (no) 1997-05-27 1999-11-26 Anvendelse av oligosakkarid for fremstilling av et medikament for forhindring av blodkoagulering i ekstra korporlige blodkretser

Country Status (12)

Country Link
US (3) US6391339B1 (no)
EP (2) EP0984785B1 (no)
JP (2) JP2002503270A (no)
AT (1) ATE307596T1 (no)
AU (1) AU8211398A (no)
BR (1) BR9809478A (no)
CA (1) CA2289522A1 (no)
DE (1) DE69832066T2 (no)
DK (1) DK0984785T3 (no)
ES (1) ES2251090T3 (no)
NO (1) NO325142B1 (no)
WO (1) WO1998053829A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8211398A (en) * 1997-05-27 1998-12-30 Akzo Nobel N.V. Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
FR2804328B1 (fr) 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
ES2861359T3 (es) * 2009-12-01 2021-10-06 Exthera Medical Corp Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie
ES2647577T3 (es) 2012-06-13 2017-12-22 Exthera Medical Corporation Uso de heparina y carbohidratos para tratar el cáncer
AU2014346668C1 (en) 2013-11-08 2018-04-26 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
DE15782250T1 (de) 2014-04-24 2017-08-10 Exthera Medical Corporation Verfahren zur Entfernung von Bakterien aus Blut unter Verwendung einer hohen Durchflussrate
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
EP3969014A4 (en) 2019-05-16 2023-01-25 ExThera Medical Corporation METHODS OF MODULATION OF ENDOTHELIAL GLYCOCALYX STRUCTURE

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
DE3008993A1 (de) * 1980-03-08 1981-10-01 Röhm Pharma GmbH, 6100 Darmstadt Pharmazeutische zubereitungen
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US4801583A (en) * 1982-01-15 1989-01-31 Choay S.A. Oligosaccharides and their biological applications
JPS63218691A (ja) * 1987-03-09 1988-09-12 Rikagaku Kenkyusho 新規な５糖類化合物及びその製造法並びに抗凝血及び抗血栓剤
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
WO1993005825A1 (en) * 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US6391369B1 (en) * 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
AU8211398A (en) * 1997-05-27 1998-12-30 Akzo Nobel N.V. Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits

Also Published As

Publication number Publication date
ES2251090T3 (es) 2006-04-16
AU8211398A (en) 1998-12-30
US6391339B1 (en) 2002-05-21
US20070197637A1 (en) 2007-08-23
EP1593380A2 (en) 2005-11-09
NO325142B1 (no) 2008-02-11
ATE307596T1 (de) 2005-11-15
EP0984785A1 (en) 2000-03-15
EP1593380A3 (en) 2008-06-11
CA2289522A1 (en) 1998-12-03
EP0984785B1 (en) 2005-10-26
DK0984785T3 (da) 2006-01-30
DE69832066D1 (de) 2005-12-01
DE69832066T2 (de) 2006-07-13
JP2002503270A (ja) 2002-01-29
BR9809478A (pt) 2000-06-20
JP2010013455A (ja) 2010-01-21
NO995800D0 (no) 1999-11-26
WO1998053829A1 (en) 1998-12-03
US20020040012A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
ATE425139T1 (de) Benzamidinderivate
Morishima et al. Antithrombotic and Hemorrhagic Effects of DX-9065a, a Direct and Selective Factor Xa Inhibitor: Comparison with a Direct Thrombin Inhibitor and Antithrombin Ill-Dependent Anticoagulants
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
DE68913557D1 (de) Peritonealdialyse-katheter.
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
FI904450A0 (fi) Nya peptidas- och isomerasinhibitorer.
NZ510509A (en) Compounds that specifically inhibit factor VIIa activity used to inhibit blood clotting and inflammatory response
IT1316986B1 (it) Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
BR9916678A (pt) Inibidores de trombina
KR890011606A (ko) 항응고제
NZ507835A (en) Heterocyclic derivatives which inhibit factor XA
DE69206465D1 (de) Peritonealdialyse-Katheter.
NO995800D0 (no) Anvendelse av oligosakkarid for forhindring av blodkoagulering i ekstrakorporeale blodkretser
ATE338030T1 (de) Amidine-inhibitoren der serine-proteasen
PL344749A1 (en) Pyrazinone protease inhibitors
EP0340305A4 (en) Hemolysis inhibitor and plasticizer.
DK0824698T3 (da) Anordning og fremgangsmåde til biospecifik fjernelse af heparin
NO952137D0 (no) Antitrombosemiddel
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
DE69118056D1 (de) Anticoagulatorische Zusammensetzung aus LACI und sulfatierten Polysacchariden
DK0811376T3 (da) Anvendelse af alkanoyl-L-carnitiner til fremstilling af et lægemiddel til behandling af inflammatoriske tarmsygdomme
DE10084241D2 (de) Heparin mit mittlerer Molmasse
FI900097A0 (fi) Foerfarande foer bestaemning av den fibrin upploesande totalaktiviteten i plasma.
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
ATE296281T1 (de) Verwendung von aminen

Legal Events

Date Code Title Description
MK1K Patent expired